These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25684509)

  • 41. [Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types].
    Sun MH; Yang F; Shen L; Zhang L; Chen Y; Cai X; Zhu XL; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):655-9. PubMed ID: 22321541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Detection of epidermal growth factor receptor gene mutations and its clinical significance in non-small cell lung cancers].
    Zhao J; Zhu Y; Zhang L; Yu YW; Zheng JM
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):671-4. PubMed ID: 22321545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors.
    Lin CC; Hsu HH; Sun CT; Shih JY; Lin ZZ; Yu CJ; Chen GG; Hsin MK; Lam KC; Leung L; Yang CH; Mok T
    J Thorac Oncol; 2010 Sep; 5(9):1424-9. PubMed ID: 20631634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions.
    Oxnard GR; Lo PC; Nishino M; Dahlberg SE; Lindeman NI; Butaney M; Jackman DM; Johnson BE; Jänne PA
    J Thorac Oncol; 2013 Feb; 8(2):179-84. PubMed ID: 23328547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
    Kim HR; Shim HS; Chung JH; Lee YJ; Hong YK; Rha SY; Kim SH; Ha SJ; Kim SK; Chung KY; Soo R; Kim JH; Cho BC
    Cancer; 2012 Feb; 118(3):729-39. PubMed ID: 21720997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.
    Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T
    Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.
    Tsao AS; Tang XM; Sabloff B; Xiao L; Shigematsu H; Roth J; Spitz M; Hong WK; Gazdar A; Wistuba I
    J Thorac Oncol; 2006 Mar; 1(3):231-9. PubMed ID: 17409862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.
    Takahashi T; Sonobe M; Kobayashi M; Yoshizawa A; Menju T; Nakayama E; Mino N; Iwakiri S; Sato K; Miyahara R; Okubo K; Manabe T; Date H
    Ann Surg Oncol; 2010 Mar; 17(3):889-97. PubMed ID: 20183914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regional distribution of genetic mutation in lung cancer in Turkey (REDIGMA).
    Özçelik N; Aksel N; Bülbül Y; Erdoğan Y; Güldaval F; Karabulut Gül Ş; Bircan A; Can A; Öz N; Şentürk A; Arınç S; Kılıç T; Kurt EB; Günay E; Çağlayan B; Çelebi Aydın D; Başyiğit İ; Savaş İ; Tatar D; Arslan S; Kömürcüoğlu B; Bayram M; Gülmez İ; Doğan ÖT; Özgün Niksarlıoğlu EY; Kaba E; Karaoğlanoğlu S; Aydın Özgür E; Özçelik AE; Özlü T;
    Tuberk Toraks; 2019 Sep; 67(3):197-204. PubMed ID: 31709951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma.
    Manceau G; Letouzé E; Guichard C; Didelot A; Cazes A; Corté H; Fabre E; Pallier K; Imbeaud S; Le Pimpec-Barthes F; Zucman-Rossi J; Laurent-Puig P; Blons H
    Int J Cancer; 2013 May; 132(9):2217-21. PubMed ID: 23047306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.
    Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Noda K; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
    Am J Clin Pathol; 2007 Jul; 128(1):100-8. PubMed ID: 17580276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies.
    Ho HL; Kao HL; Yeh YC; Chou TY
    Diagn Pathol; 2019 Jun; 14(1):59. PubMed ID: 31221183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathologic characteristics and EGFR mutations in lung cancer patients aged below 45 years.
    Xia J; Li H; Ji Y; Mi C; Chen G; Li P; Zhang R; Chen W; Wang J
    Curr Probl Cancer; 2019 Aug; 43(4):363-370. PubMed ID: 30522775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib.
    Kimura H; Fujiwara Y; Sone T; Kunitoh H; Tamura T; Kasahara K; Nishio K
    Br J Cancer; 2006 Nov; 95(10):1390-5. PubMed ID: 17060940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung.
    Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
    Mod Pathol; 2007 Sep; 20(9):967-73. PubMed ID: 17618248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in epidermal growth factor receptor gene mutations and relationship with clinicopathological features in NSCLC between Uygur and Han ethnic groups.
    Zhang Y; Wang Q; Han ZG; Shan L
    Asian Pac J Cancer Prev; 2013; 14(5):2879-83. PubMed ID: 23803047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China.
    Zhao Y; Dong Y; Zhao R; Zhang B; Wang S; Zhang L; Hu M; He Q; Zhang W; Han B
    Clin Lung Cancer; 2020 Sep; 21(5):e355-e362. PubMed ID: 32139332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimens.
    Bar J; Damianovich M; Hout Siloni G; Dar E; Cohen Y; Perelman M; Ben Nun A; Simansky D; Yellin A; Urban D; Onn A
    Clin Lung Cancer; 2014 Mar; 15(2):159-65. PubMed ID: 24370118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancer.
    Sasaki H; Okuda K; Takada M; Kawahara M; Kitahara N; Matsumura A; Iuchi K; Kawaguchi T; Kubo A; Endo K; Kawano O; Yukiue H; Yano M; Fujii Y
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1371-6. PubMed ID: 18478265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An alternative method for screening EGFR mutation using RFLP in non-small cell lung cancer patients.
    Kawada I; Soejima K; Watanabe H; Nakachi I; Yasuda H; Naoki K; Kawamura M; Eguchi K; Kobayashi K; Ishizaka A
    J Thorac Oncol; 2008 Oct; 3(10):1096-103. PubMed ID: 18827604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.